Gossamer Bio Inc GOSS

US Biotechnology

$10.94 ▲ +0.09% (+$0.01)

🎈 Low Float 🎢 High Beta

Open $10.93

Prev Close $10.93

Day Range $10.22 – $11.01

52W Range $9.10 – $309.60

Market Cap $66.85M

Beta 2.29

EPS (TTM) $-0.56

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2019-02-08
Shares Out.	488,850,000
Website	gossamerbio.com/ ↗
Phone	13026365400
Employees	162
Revenue	$9.2M
Gross Profit	$9.2M
Net Income	$16.9M
Free Cash Flow	-$162.6M
Total Assets	$76.9M
Total Liabilities	$170.9M
Equity	-$94.0M

About Gossamer Bio Inc

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).

Gossamer Bio Inc is a publicly traded company under the ticker symbol GOSS on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.